HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Simon Lord Selected Research
Simon Lord Research Topics
Disease
11
Neoplasms (Cancer)
11/2022 - 08/2011
5
Breast Neoplasms (Breast Cancer)
01/2022 - 12/2010
3
Hypoxia (Hypoxemia)
01/2019 - 08/2011
2
Disease Progression
01/2021 - 01/2019
1
Cardiotoxicity
01/2022
1
Brain Neoplasms (Brain Tumor)
01/2022
1
Glioblastoma (Glioblastoma Multiforme)
01/2022
1
Heart Failure
01/2022
1
Inflammation (Inflammations)
01/2022
1
Lymphoma (Lymphomas)
01/2022
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022
1
Neoplasm Metastasis (Metastasis)
01/2022
1
Left Ventricular Dysfunction
01/2022
1
Hypersensitivity (Allergy)
01/2021
1
Ataxia Telangiectasia (Louis Bar Syndrome)
01/2021
1
Frailty
01/2021
1
Skin Neoplasms (Skin Cancer)
01/2021
1
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2015
1
Carcinogenesis
10/2014
Drug/Important Bio-Agent (IBA)
2
Adenosine Triphosphate (ATP)
IBA
11/2022 - 10/2014
2
Biomarkers (Surrogate Marker)
IBA
01/2022 - 08/2011
2
Pharmaceutical Preparations
IBA
10/2021 - 01/2016
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
10/2021 - 08/2016
2
Hormones (Hormone)
IBA
01/2019 - 01/2019
1
candesartan
IBA
01/2022
1
Carvedilol (Coreg)
FDA Link
Generic
01/2022
1
Adrenergic Receptors (Adrenergic Receptor)
IBA
01/2022
1
Troponin
IBA
01/2022
1
Anthracyclines
IBA
01/2022
1
Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)
IBA
01/2022
1
Troponin I
IBA
01/2022
1
Gadolinium DTPA (Magnevist)
FDA Link
01/2022
1
Designed Ankyrin Repeat Proteins
IBA
10/2021
1
MP0250
IBA
10/2021
1
Capecitabine (Xeloda)
FDA Link
01/2021
1
berzosertib
IBA
01/2021
1
Alanine Transaminase (SGPT)
IBA
01/2021
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
01/2021
1
VX (EDIM)
IBA
01/2021
1
Platinum
IBA
01/2021
1
Protein Kinases (Protein Kinase)
IBA
01/2021
1
3' Untranslated Regions (3' UTR)
IBA
01/2021
1
P-2 (P 2)
IBA
01/2021
1
Glutamine (L-Glutamine)
FDA Link
01/2019
1
Estrogen Receptors
IBA
01/2019
1
Estrogen Receptor Modulators (Antiestrogen)
IBA
01/2019
1
Fulvestrant (Faslodex)
FDA Link
01/2019
1
Ado-Trastuzumab Emtansine
IBA
01/2019
1
Amino Acids
FDA Link
01/2019
1
trastuzumab duocarmazine
IBA
01/2019
1
Bevacizumab (Avastin)
FDA Link
08/2016
1
Oxygen (Dioxygen)
IBA
01/2016
1
fibrin fragment D (D-dimer)
IBA
01/2015
1
Imatinib Mesylate (Gleevec)
FDA Link
01/2015
1
Perilipin-2
IBA
10/2014
1
Fatty Acids (Saturated Fatty Acids)
IBA
10/2014
1
Glycogen
IBA
10/2014
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
10/2014
1
Lipids
IBA
10/2014
1
MicroRNAs (MicroRNA)
IBA
08/2011
Therapy/Procedure
8
Therapeutics
11/2022 - 12/2010
3
Drug Therapy (Chemotherapy)
01/2022 - 01/2021
1
Intravenous Administration
01/2022
1
Combination Drug Therapy (Combination Chemotherapy)
01/2021
1
Neoadjuvant Therapy
08/2016